We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Toolkit for Reductive Amination in Drug Discovery

By Biotechdaily staff writers
Posted on 23 Jun 2003
A toolkit is designed to simplify the incorporation of reductive amination in chemical drug discovery.

Conventional product workup and purification for reductive amination can be time-consuming and inefficient. More...
In contrast, the resin-bound reagents and scavengers in the toolkit deliver high-purity products requiring only a simple filtration step for product purification. The format allows rapid comparison of pre-defined protocols to determine the best procedure for specific target compounds.

The resin-bound reductants in the toolkit include MP-triacetoxyborohydride and MP-cyanoborohydride. The toolkit is the product of Argonaut Technologies, Inc. (Foster City, CA, USA; www.argotech.com). The company notes that according to The Comprehensive Medicinal Drug Database, about 75% of all chemical drugs currently in development could utilize this reaction.

"Drug discovery and medicinal chemists need simpler access to the chemical compounds generated using this reaction class,” said Howard D. Goldstein, senior vice president of Argonaut Technologies. "Reductive amination is a powerful tool that's used routinely to generate structurally diverse drug candidates.”




Related Links:
Argonaut

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Immunofluorescence Analyzer
IFA System
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.